Key result
Minimally invasive direct coronary artery bypass (MIDCAB) grafting has an expanded role in treating coronary artery disease, including use in inferior/lateral stenoses and reoperative settings.
The role of MIDCAB grafting has expanded beyond simple revascularization to include multi-vessel disease, reoperative settings, and inferior/lateral stenoses.
May support expanded MIDCAB use in complex CAD; leaves open confirmation by randomized trials.
The evolution of minimally invasive direct coronary artery bypass (MIDCAB) grafting has extended the role of this approach for limited coronary revascularization. MIDCAB techniques can now be used to address isolated stenoses in the inferior and lateral coronary distributions. MIDCAB techniques are increasingly being used in the reoperative setting, and multiple vessels can be bypassed during a single operation. This article reviews the expanded role of MIDCAB grafting in the treatment of coronary artery disease.
No takes yet. Share an insight, caveat, or question.
James D. Fonger (1998) conducted a review in Coronary artery disease. Minimally invasive direct coronary artery bypass (MIDCAB) grafting was evaluated. Minimally invasive direct coronary artery bypass (MIDCAB) grafting has an expanded role in treating coronary artery disease, including use in inferior/lateral stenoses and reoperative settings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: